Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation
Authors:
- Wei ZhaoWZWei Zhao
- Gang WuGWGang Wu
- 1 November 2009
- journal article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 18 (6) , 510-517
Abstract
The objective of this study was to investigate the effects of angiotensin II and valsartan, an angiotensin II type 1 receptor (AT1R) blocker, combined with γ-radiation, on vascular endothelial growth factor (VEGF) expression, radiosensitivity, invasive potential, and proliferation activity of nasopharyngeal carcinoma (CNE-2) in vitro. Reverse-transcription PCR and ELISA assayed VEGF expression and secretion in CNE-2 in vitro. Radiosensitization of valsartan on CNE-2 cell in vitro was investigated by a colony-forming assay. The effect of AT1R blocker combined with radiation on invasive potential of CNE-2 cells was evaluated using 24-well Matrigel invasion chambers (Transwell). The apoptosis-inducing effect of valsartan combined with irradiation on apoptosis of CNE-2 was identified by flow cytometry. AT1R was expressed in nasopharyngeal carcinoma cell lines CNE-1 and CNE-2. The expression and secretion of VEGF in CNE-2 could be induced either by angiotensin II or γ-radiation. Furthermore, the suppression of AT1R activation reduced cellular proliferation, invasive potential and resistance to γ-radiation in nasopharyngeal carcinoma cells. In conclusion, AT1R plays a significant role not only in proliferation and invasion, but also in radiation resistance in nasopharyngeal carcinoma cells, the mechanism of which may be involved in the regulation of VEGF expression and secretion.Keywords
This publication has 22 references indexed in Scilit:
- Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat gliomaBritish Journal of Cancer, 2005
- Activation of invasiveness of cervical carcinoma cells by angiotensin IIAmerican Journal of Obstetrics and Gynecology, 2004
- Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastomaBritish Journal of Cancer, 2004
- Role of host angiotensin II type 1 receptor in tumor angiogenesis and growthJournal of Clinical Investigation, 2003
- Matrix Metalloproteinases Cleave Connective Tissue Growth Factor and Reactivate Angiogenic Activity of Vascular Endothelial Growth Factor 165Journal of Biological Chemistry, 2002
- Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonistFEBS Letters, 2001
- The Relationship Between Microvessel Density, the Expression of Vascular Endothelial Growth Factor (VEGF), and the Extension of Nasopharyngeal CarcinomaThe Laryngoscope, 2000
- Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1998
- The Role of Angiotensin Receptors in Cardiovascular DiseasesAnnals of Medicine, 1997